The quarter shows solid execution with margin expansion driven by higher HVS mix, particularly biologics and GLP-1 therapies. Monitor Q3 for Engineering segment recovery and new plant ramp timelines. The narrowed revenue guidance suggests conservatism; any beat on guidance could provide upside.
Price Chart
Executive Summary
Stevanato Group reported Q2 2026 revenue of €302M, up 8% YoY, driven by 9% growth in BDS and 16% growth in high-value solutions (HVS). Adjusted EBITDA margin expanded 280bps to 26.0%, reflecting favorable HVS mix and operational leverage. The company updated FY2026 guidance, narrowing revenue to €1.260–1.280B (from €1.260–1.290B) and raising the adjusted EBITDA margin mid-point slightly to 26.8%, supported by continued momentum in biologics and GLP-1 therapies.
Key Facts
- Q2 2026 revenue of €302M, +8% YoY (vs €280M)
- HVS revenue of €136M, +16% YoY (45% of total revenue)
- Adjusted EBITDA of €78.7M, +21% YoY; margin 26.0% (+280bps)
- Adjusted operating profit margin 18.0% (+250bps)
- Adjusted diluted EPS of €0.14 (net profit €23.0M, EPS €0.08)
- Divested non-HVS subsidiary Balda C. Brewer; one-time loss of €12.2M
- FY2026 guidance: revenue €1.260–1.280B, adjusted EBITDA €335–345M, adjusted DEPS €0.60–0.62
- FCF expected from breakeven to positive €20M for full year
Financial Impact
Q2 revenue grew 8% YoY, adjusted EBITDA margin expanded 280bps, and guidance mid-point for adjusted EBITDA margin slightly raised; impact moderate and positive.
Risk Factors
- FX translation headwinds and higher utility costs may pressure margins
- Engineering segment sales cycles remain elongated, keeping segment decline risk
- Execution risk on Latina and Fishers capacity expansions and customer validations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-332815 |
| Document: 6-k_presentation_aug_4_2.htm | 0001193125-26-332815 |
| Document: 0001193125-26-332815-index-headers.html | 0001193125-26-332815 |
| Document: 0001193125-26-332815-index.html | 0001193125-26-332815 |
| Document: 0001193125-26-332815.txt | 0001193125-26-332815 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 11w ago | Insider Cluster | $21.05 $20.24 | ▼ −3.85% | ▼ −2.79% | $19.88 (−5.56%) |
Aug 6, 2026 11w ago | 6-K | $20.27 $20.51 | ▲ +1.18% | ▲ +1.58% | $19.88 (−1.92%) |
Aug 4, 2026 11w ago | 6-K | $20.10 $20.73 | ▲ +3.13% | ▲ +3.74% | $19.88 (−1.09%) |
May 11, 2026 24w ago | 6-K | $18.28 $18.03 | ▼ −1.34% | ▼ −1.04% | $19.88 (+8.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers